Cargando…

Correction: Repurposed agents in the Alzheimer’s disease drug development pipeline

Detalles Bibliográficos
Autores principales:	Bauzon, Justin, Lee, Garam, Cummings, Jeffrey
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2023
Materias:	Correction
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10440904/ https://www.ncbi.nlm.nih.gov/pubmed/37605263 http://dx.doi.org/10.1186/s13195-023-01284-9

Ejemplares similares

Repurposed agents in the Alzheimer’s disease drug development pipeline
por: Bauzon, Justin, et al.
Publicado: (2020)

Who funds Alzheimer's disease drug development?
por: Cummings, Jeffrey, et al.
Publicado: (2021)

Alzheimer's drug-development pipeline: 2016
por: Cummings, Jeffrey, et al.
Publicado: (2016)

Alzheimer's disease drug development pipeline: 2018
por: Cummings, Jeffrey, et al.
Publicado: (2018)

Alzheimer's disease drug development pipeline: 2017
por: Cummings, Jeffrey, et al.
Publicado: (2017)

Alzheimer's disease drug development pipeline: 2019
por: Cummings, Jeffrey, et al.
Publicado: (2019)

Alzheimer's disease drug development pipeline: 2020
por: Cummings, Jeffrey, et al.
Publicado: (2020)

Alzheimer's disease drug development pipeline: 2021
por: Cummings, Jeffrey, et al.
Publicado: (2021)

Alzheimer's disease drug development pipeline: 2023
por: Cummings, Jeffrey, et al.
Publicado: (2023)

Alzheimer's disease drug development pipeline: 2022
por: Cummings, Jeffrey, et al.
Publicado: (2022)

Alzheimer’s disease drug-development pipeline: few candidates, frequent failures
por: Cummings, Jeffrey L, et al.
Publicado: (2014)

Correction to: New approaches to symptomatic treatments for Alzheimer’s disease
por: Cummings, Jeffrey
Publicado: (2021)

Author Correction: Predicting Alzheimer’s disease progression using multi-modal deep learning approach
por: Lee, Garam, et al.
Publicado: (2023)

Alzheimer’s Disease Drug Development Pipeline 2020
por: Sabbagh, M.N.
Publicado: (2020)

A Functional Pipeline of Genome-Wide Association Data Leads to Midostaurin as a Repurposed Drug for Alzheimer’s Disease
por: Esteban-Martos, Alvaro, et al.
Publicado: (2023)

Erratum: Alzheimer's disease drug development pipeline: 2023
Publicado: (2023)

Artificial intelligence framework identifies candidate targets for drug repurposing in Alzheimer’s disease
por: Fang, Jiansong, et al.
Publicado: (2022)

In silico repurposing of antipsychotic drugs for Alzheimer’s disease
por: Kumar, Shivani, et al.
Publicado: (2017)

Correction to: Scope of repurposed drugs against the potential targets of the latest variants of SARS-CoV-2
por: Niranjan, Vidya, et al.
Publicado: (2022)

Drug repurposing strategies in the development of potential antifungal agents
por: Zhang, Qian, et al.
Publicado: (2021)

Correction: Rapid Identification of Antifungal Compounds against Exserohilum rostratum Using High Throughput Drug Repurposing Screens
por: Sun, Wei, et al.
Publicado: (2013)

Correction: Rapid Identification of Antifungal Compounds against Exserohilum rostratum Using High Throughput Drug Repurposing Screens
por: Sun, Wei, et al.
Publicado: (2013)

ASGARD is A Single-cell Guided Pipeline to Aid Repurposing of Drugs
por: He, Bing, et al.
Publicado: (2023)

ASGARD: A Single-cell Guided Pipeline to Aid Repurposing of Drugs
por: He, Bing, et al.
Publicado: (2021)

Single-cell-led drug repurposing for Alzheimer’s disease
por: Parolo, Silvia, et al.
Publicado: (2023)

Potential repurposing of oncology drugs for the treatment of Alzheimer's disease
por: Araki, Wataru
Publicado: (2013)

Repurposing Licensed Drugs for Use Against Alzheimer’s Disease
por: Norins, Leslie C.
Publicado: (2021)

Marine Natural Products, Multitarget Therapy and Repurposed Agents in Alzheimer’s Disease
por: Martins, Márcia, et al.
Publicado: (2020)

A Prospective Repurposing of Dantrolene as a Multitarget Agent for Alzheimer’s Disease
por: Bolognino, Isabella, et al.
Publicado: (2019)

The “rights” of precision drug development for Alzheimer’s disease
por: Cummings, Jeffrey, et al.
Publicado: (2019)

Repurposing old drugs as antiviral agents for coronaviruses
por: Yang, Cheng-Wei, et al.
Publicado: (2020)

Correction: LotuS: an efficient and user-friendly OTU processing pipeline
por: Hildebrand, Falk, et al.
Publicado: (2014)

Correction to: PhosPiR: an automated phosphoproteomic pipeline in R
por: Hong, Ye, et al.
Publicado: (2022)

Correction to: Induction of immunogenic cell death in radiation-resistant breast cancer stem cells by repurposing anti-alcoholism drug disulfiram
por: Sun, Ting, et al.
Publicado: (2020)

Drug repurposing: re-inventing therapies for cancer without re-entering the development pipeline—a review
por: Siddiqui, Shafina, et al.
Publicado: (2022)

Correction: The Zinc Dyshomeostasis Hypothesis of Alzheimer's Disease
por: Craddock, Travis J. A., et al.
Publicado: (2012)

Correction: The Zinc Dyshomeostasis Hypothesis of Alzheimer's Disease
por: Craddock, Travis J. A., et al.
Publicado: (2012)

Correction: The Zinc Dyshomeostasis Hypothesis of Alzheimer's Disease
por: Craddock, Travis J. A., et al.
Publicado: (2013)

An Alternative Pipeline for Glioblastoma Therapeutics: A Systematic Review of Drug Repurposing in Glioblastoma
por: Lyne, Seán B., et al.
Publicado: (2021)

Correction: Predicting progression of Alzheimer's disease
por: Doody, Rachelle S, et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_nb1nsfhetg76gntu7q514rm2te